NYSE:CANF | Cash Flow Statement | Can-Fite BioPharma Ltd.

Complete source-backed cash-flow history.

Available history
2018-12-31 to 2025-12-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$9.83M$24,000.00-$8.95M$2,000.00-$2,000.00$9.64M
2024-12-31-$7.88M$7,000.00-$7.64M$5,000.00$1.5M$6.71M
2023-12-31-$7.63M$15,000.00-$8.44M$2,000.00$498,000.00$9.14M
2022-12-31-$10.17M$14,000.00-$10.8M$9,000.00$9.5M
2021-12-31-$12.62M$14,000.00-$9.86M$11,000.00-$14.51M$2.59M$20.46M
2020-12-31-$14.44M$12,000.00-$12.06M$26,000.00-$26,000.00$715,000.00$17.68M
2019-12-31-$12.63M$14,000.00-$11.08M$3,000.00-$3,000.00$10.17M
2018-12-31-$6.57M$14,000.00-$4.16M$33,000.00-$33,000.00$4.39M